Dermatology Interview Questions & Answers

← All NHS Medical and Dental interview questions

About this NHS interview question bank

To prepare for an NHS dermatology interview, expect questions on urgent suspected skin cancer clinics and dermoscopy, dermatological emergencies such as SJS/TEN, erythroderma and eczema herpeticum, safe prescribing of isotretinoin, methotrexate and biologics, consent for minor surgery, and how you communicate with patients whose skin condition affects their mental health. Panels for Clinical Fellow and Specialty Doctor posts also look for GMC Good Medical Practice, safeguarding, skin of colour awareness, audit and teaching, so prepare short spoken examples from your own clinics and ward referrals.

This bank contains 40 original practice questions with first-person model answers written for doctors applying to NHS dermatology posts, pitched mainly at Clinical Fellow and Specialty Doctor level, with a selection aimed at senior Specialty Doctor, Specialist and Consultant interviews. It covers skin cancer pathways, inpatient referrals, emergencies, systemic and biologic therapy, teledermatology, waiting list pressures and the psychological side of skin disease. Each question explains what the panel is really assessing, the points you must hit, the mistakes to avoid and the guidance worth reading, so you can build answers that sound like a safe, thoughtful dermatologist rather than a textbook.

 

What this question bank covers

• Motivation for dermatology
• Urgent suspected skin cancer clinics and dermoscopy
• Melanoma and keratinocyte cancer pathways
• Dermatological emergencies: SJS/TEN, erythroderma, eczema herpeticum
• Inpatient referrals
• Isotretinoin and pregnancy prevention
• Methotrexate and biologic safety
• Minor surgery, consent and wrong-site prevention
• Teledermatology and advice and guidance
• Skin of colour and diagnostic bias
• Psychological impact of skin disease
• Safeguarding children and adults
• Clinical photography and confidentiality
• Waiting list pressures
• GMC Good Medical Practice
• Audit, QI and teaching
• Career development and the portfolio pathway

 

40 NHS interview questions with full model answers. The first 8 are free to read below. Unlock the remaining 32 for £2.99 (12 months' access).

These are original practice questions written to reflect how NHS interviews are run. They are not leaked or official questions, and Healthcare Interview Prep is independent of the NHS.

 

 

Free NHS interview questions and model answers

 

 

Question 1: Why do you want to work in dermatology?

Motivation question  ·  Motivation

 

What the interview panel is assessing

The panel wants a genuine, personal reason that goes beyond liking a visual specialty or regular hours. They are listening for an understanding of how varied dermatology really is, from skin cancer and surgery to sick inpatients and chronic disease, and for respect for the impact skin disease has on people's lives.

 

Model answer

I think it started with a patient rather than a textbook. As a medical SHO I looked after a man in his fifties admitted with a flare of psoriasis that had become almost erythrodermic. On paper he was there for fluids and temperature control, but what struck me was how ashamed he was. He kept his curtains closed, wouldn't let his grandchildren visit and told me he'd stopped swimming years ago. The dermatology registrar came, changed his treatment, sorted out a plan for systemic therapy and, just as importantly, sat down and talked to him as a person. Two weeks later he was a different man.

That showed me two things I still love about the specialty. The first is that it's genuinely medical. Skin can be the first sign of lupus, a drug reaction, a malignancy or an infection, and the diagnostic reasoning is detailed and satisfying. The second is that the impact on quality of life is huge and often underestimated. Acne, eczema and hidradenitis can affect someone's confidence, relationships and work in a way that a normal blood test never shows.

I also enjoy the practical side. I like minor surgery, I've become much more confident with dermoscopy, and I find skin cancer clinics rewarding because you can make a real difference by catching something early. At the same time I know it isn't an easy option. Clinics are busy, waiting lists are long, and there are real emergencies like toxic epidermal necrolysis where the dermatologist matters a great deal.

So for me it's the mix: careful diagnosis, hands-on procedures, long-term relationships with patients, and the chance to give people back a bit of normal life.

 

Why this answer works

It opens with a specific memory, which makes the motivation believable, and it shows the candidate understands both the medical depth and the psychological weight of skin disease. It mentions procedures, skin cancer and emergencies, which shows awareness of the full scope of the job, and it is honest that the specialty is not a soft option.

 

Key points to include

• A specific moment or patient that drew you in
• Dermatology as a medical specialty linked to systemic disease
• The psychological and quality-of-life impact of skin disease
• Interest in procedures, dermoscopy and skin cancer work
• Realism about clinic pressure, waiting lists and emergencies

 

Common mistakes to avoid

• Saying you chose dermatology for the lifestyle or lack of on-call
• Describing it only as a visual pattern-recognition specialty
• Ignoring inpatient and emergency dermatology entirely
• Giving a generic answer that could apply to any specialty

 

NHS values and standards

Compassion; Improving lives; Commitment to quality of care; GMC Good Medical Practice: patients, partnership and communication

 

Further reading

• GMC Good Medical Practice
• NHS Constitution for England
• British Association of Dermatologists (BAD) information on careers in dermatology

 

 

Question 2: You are in a busy urgent suspected skin cancer clinic and see a 62-year-old with a changing pigmented lesion on her back. Talk us through your approach.

Clinical Scenario question  ·  Clinical Scenario

 

What the interview panel is assessing

This tests safe, structured skin cancer assessment at the level the post expects. The panel wants to hear a focused history, full skin examination, sensible use of dermoscopy, a clear management decision with the correct biopsy approach for suspected melanoma, and good communication and safety-netting.

 

Model answer

I'd start with the story, because change is the most important thing. I'd ask when she or someone else first noticed it, how it's changed in size, shape or colour, and whether it's itched, bled or crusted. Then risk factors: previous skin cancer, family history of melanoma, lots of moles, sunburn history, sunbed use, skin type and any immunosuppression. I'd also check what the referral letter and any GP photographs show.

Then I'd offer a full skin examination with a chaperone offered, not just a look at the lesion on her back. Patients often can't see their own backs, and it's common to find a second lesion that matters more. I'd look at the lesion with the naked eye first, thinking about asymmetry, irregular border, colour variation and whether it's an ugly duckling compared with her other moles. Then dermoscopy, looking for features like an atypical network, irregular streaks or dots, blue-white structures or regression. I'd also feel for regional lymph nodes.

If I'm worried about melanoma, the standard approach is an excision biopsy of the whole lesion with a narrow margin, rather than a punch or shave of part of it, so the pathologist can give an accurate Breslow thickness. There are exceptions, such as a large lesion on the face, and if I wasn't sure I'd discuss with the consultant. I'd take a dermoscopic and clinical photograph, mark the site carefully and document the size and location precisely, because a back lesion is exactly where wrong-site problems can happen later.

I'd explain honestly that I'm concerned enough to remove it and send it for testing, without frightening her unnecessarily, and tell her how and when she'll get results. Before she left, I'd give her information on skin self-examination and sun protection, and make sure the request was tracked so the result came back to us and wasn't lost. If the lesion looked benign, I'd still explain why, give clear advice on what changes should bring her back, and document my dermoscopic findings so the decision is defensible.

 

Why this answer works

The answer follows a logical clinical sequence and includes the two things panels most want to hear at this level: a full skin check and the correct excision biopsy approach for suspected melanoma. It also covers documentation, photography, site marking and result tracking, which shows awareness of the system as well as the diagnosis.

 

Key points to include

• Focused history centred on change and risk factors
• Full skin examination with a chaperone offered, plus lymph nodes
• Naked-eye assessment followed by structured dermoscopy
• Excision biopsy of the whole lesion for suspected melanoma, with exceptions discussed with a senior
• Photograph, document and track the result
• Clear communication and safety-netting

 

Common mistakes to avoid

• Only examining the lesion that was referred
• Suggesting a shave or partial punch biopsy for a suspected melanoma without justification
• Forgetting result tracking and follow-up arrangements
• Overloading the patient with alarming language before there is a diagnosis

 

NHS values and standards

Commitment to quality of care; Compassion; GMC Good Medical Practice: knowledge, skills and development

 

Further reading

• NICE guideline on melanoma: assessment and management
• NICE guideline on suspected cancer: recognition and referral
• BAD guidelines for the management of cutaneous melanoma
• NHS England Faster Diagnosis Standard

 

 

Question 3: You are bleeped at 4pm on a Friday about a ward patient who has become red from head to toe. How would you manage this referral?

Clinical Scenario question  ·  Clinical Scenario

 

What the interview panel is assessing

The panel wants to know that you recognise erythroderma as a dermatological emergency with systemic consequences, that you can assess the patient safely and find the cause, and that you will not leave a sick patient without a clear plan over the weekend. Escalation and communication with the ward team are central.

 

Model answer

The first thing I'd do is take it seriously, because widespread redness covering most of the skin is erythroderma until proven otherwise, and that can make someone very unwell. I'd ask the ward doctor a few quick questions on the phone: how the patient is physiologically, their NEWS2 score, any new medicines in the last few weeks, and whether there's blistering, skin peeling or mouth or eye involvement. If there were mucosal involvement or skin coming away, I'd be thinking about SJS or TEN and would go straight away and let my consultant know.

Even without that, I'd go and see the patient that afternoon rather than leave advice by phone. I'd look at the whole skin and the mucosa, and think about the common causes: a flare of known psoriasis or eczema, a drug reaction, including DRESS, and less commonly lymphoma such as Sézary syndrome. I'd go through the drug chart carefully with dates of starting, and look for clues like a facial swelling, lymph nodes or a fever.

The systemic side matters as much as the diagnosis. These patients lose heat, fluid and protein through their skin and are prone to infection, so I'd advise a warm room, fluid balance, regular observations, bloods including full blood count with eosinophils, renal and liver function and albumin, and swabs if there's any sign of infection. Supportive skin care is a big part of treatment: generous emollients applied regularly, usually with a moderate topical steroid depending on the cause. Any likely culprit drug should be stopped after discussion with the medical team.

Because it's Friday, I'd discuss the patient with the on-call dermatology consultant before I left, write a clear plan in the notes covering monitoring, skin care and what would trigger escalation, and make sure the ward knew how to reach dermatology over the weekend. I'd also hand over to the medical team directly. A good plan written at 5pm can prevent a much worse phone call at 2am.

 

Why this answer works

It identifies erythroderma as an emergency, screens for SJS/TEN and DRESS, and covers both diagnosis and the systemic risks of skin failure. The Friday detail is handled properly through senior discussion, a written plan and direct handover, which is what panels want to hear about safe inpatient dermatology.

 

Key points to include

• Recognise erythroderma as an emergency and see the patient in person
• Screen for mucosal involvement, blistering and drug reactions such as SJS/TEN and DRESS
• Review the drug chart with start dates
• Manage the systemic risks: temperature, fluids, infection, protein loss
• Supportive skin care with emollients and appropriate topical steroid
• Senior discussion and a clear written plan before the weekend

 

Common mistakes to avoid

• Giving phone advice only without seeing the patient
• Focusing on the rash and forgetting fluid balance and infection risk
• Not reviewing medication history
• Leaving no clear plan or escalation route over the weekend

 

NHS values and standards

Commitment to quality of care; Working together for patients; GMC Good Medical Practice: safety and quality

 

Further reading

• British Association of Dermatologists guidance on inpatient and emergency dermatology
• Royal College of Physicians National Early Warning Score (NEWS2)
• GMC Good Medical Practice
• Local trust policy on inpatient dermatology referrals

 

 

Question 4: A 17-year-old with severe nodular acne wants to start isotretinoin. How would you have the consent and safety conversation?

Communication question  ·  Communication

 

What the interview panel is assessing

This checks that you can explain a high-risk medicine to a young person in a way they understand, and that you know the safety framework: the pregnancy prevention programme for anyone who could become pregnant, mental health and sexual function monitoring, and the additional safeguards for under-18s. The panel also wants to hear respect for the young person's autonomy alongside involving parents appropriately.

 

Model answer

I'd start by finding out what they already know and what they're hoping for, because by the time a young person gets to us they've often read a lot online, some of it accurate and some not. I'd explain that isotretinoin is very effective for severe acne and can give long-lasting improvement, but it's a strong medicine, so we take the safety side seriously.

I'd go through the common side effects first, like dry lips, dry skin and nosebleeds, because those are what they'll notice. Then I'd talk honestly about mood. I'd explain that some people report low mood, anxiety or, rarely, thoughts of self-harm, and that we'll ask about this at every appointment. I'd ask about their current mental health and any past history, and agree that they or their family can contact us if they notice any change. Current MHRA guidance also asks us to discuss possible sexual side effects, so I'd mention that in a straightforward way.

If the patient could become pregnant, I'd explain clearly and without judgement that isotretinoin can cause serious harm to a baby, which is why there's a pregnancy prevention programme. That means highly effective contraception, pregnancy testing before starting, during treatment and after stopping, and signing an acknowledgement form. I'd make sure I had part of the conversation with the young person on their own, because they may not want to talk about contraception or relationships in front of a parent, and that needs to be respected.

For under-18s, the current national safeguards require two appropriately experienced prescribers to agree that treatment is justified before starting, so I'd make sure that was documented in line with our trust's process. I'd check understanding by asking them to tell me back the key points, give written information, and make sure they know they don't have to decide today. If I had any doubts about their capacity to consent or any safeguarding concerns from the private part of the conversation, I'd discuss them with my consultant.

 

Why this answer works

The answer is structured, honest and age-appropriate. It covers the safety areas panels expect, including mood, sexual side effects, pregnancy prevention and the under-18 two-prescriber requirement, while showing respect for confidentiality by speaking to the young person alone. It also uses teach-back to check understanding.

 

Key points to include

• Explore expectations and correct misinformation
• Discuss common side effects, mood and sexual function honestly
• Pregnancy prevention programme for anyone who could become pregnant
• Part of the consultation with the young person alone
• Two-prescriber agreement for under-18s as per current national guidance and local process
• Check understanding and give written information

 

Common mistakes to avoid

• Rushing straight to the forms without exploring the patient's concerns
• Not mentioning mood changes or sexual side effects
• Discussing contraception only in front of a parent
• Being vague or out of date about pregnancy prevention requirements

 

NHS values and standards

Respect and dignity; Compassion; Everyone counts; GMC Good Medical Practice and GMC guidance on decision making and consent

 

Further reading

• MHRA guidance on isotretinoin, including the 2023 additional safety measures
• Isotretinoin Pregnancy Prevention Programme
• GMC guidance: 0 to 18 years
• GMC guidance on decision making and consent
• BAD patient information leaflet on isotretinoin

 

 

Question 5: How do you make sure you diagnose skin disease accurately in patients with darker skin tones?

Equality & Diversity question  ·  Equality & Diversity

 

What the interview panel is assessing

The panel wants to see that you understand diagnostic bias in dermatology, including how teaching images have historically under-represented darker skin, and that you have concrete ways to reduce its impact. They are looking for humility, practical skills and an understanding of how bias can lead to delayed diagnosis and health inequality.

 

Model answer

I think the honest starting point is that most of the images I learned from at medical school were on white skin. Words like red, pink and erythema are built into how we describe inflammation, but in darker skin inflammation often looks violaceous, dusky, grey or simply darker than the surrounding skin. If you're waiting to see redness, you can miss eczema, cellulitis or a drug eruption entirely, or underestimate how severe it is.

I learned this properly in clinic. A young Black man had been treated in primary care for months for what was thought to be fungal infection, and it turned out to be atopic eczema with quite marked lichenification and post-inflammatory hyperpigmentation. His severity scores had been underestimated because the redness wasn't obvious. Since then I've made a point of feeling the skin for warmth, thickening and texture, asking the patient how their skin looks compared with normal, and using good lighting.

I've also tried to fill the gaps in my own learning. I use image resources that include a wide range of skin tones, and I look at what's different in presentation, for example that melanoma in people with darker skin is more often found on the palms, soles and nails, and that keloid scarring and dyspigmentation matter a lot in planning procedures. Pigmentary changes can be the main concern for the patient even after the inflammation has settled, so I make sure I treat that seriously rather than calling it cosmetic.

Finally, I'd want to help the department look at this too, for example by checking that our patient information leaflets and teaching sets include different skin tones, and by being open with colleagues when I'm unsure. Getting this right is about fairness as much as accuracy. Everyone counts, and every patient deserves the same quality of diagnosis.

 

Why this answer works

The answer admits a real gap in training without being defensive, gives a believable example of harm from bias, and lists practical techniques like palpation and asking about baseline skin. It also shows wider awareness, such as acral melanoma and pigmentary concerns, and a willingness to improve departmental resources.

 

Key points to include

• Inflammation looks different in darker skin and redness can be absent
• Diagnostic bias can lead to delayed diagnosis and underestimated severity
• Practical techniques: palpation, lighting, asking about baseline skin
• Awareness of presentations such as acral melanoma, keloids and pigmentary change
• Personal learning plus improving departmental resources

 

Common mistakes to avoid

• Saying you treat everyone the same so bias is not an issue
• Describing pigmentary change as purely cosmetic
• Talking only in general terms about diversity with no clinical detail
• Using outdated or stereotyped language

 

NHS values and standards

Everyone counts; Respect and dignity; Commitment to quality of care; GMC Good Medical Practice: treating patients fairly

 

Further reading

• Equality Act 2010
• GMC Good Medical Practice
• NHS England Core20PLUS5 approach to reducing healthcare inequalities
• Mind the Gap: clinical handbook of signs and symptoms in black and brown skin

 

 

Question 6: What does GMC Good Medical Practice mean to you in your day-to-day work as a dermatologist?

NHS Values question  ·  NHS Values

 

What the interview panel is assessing

The panel is checking that you know the current version of Good Medical Practice and can link its themes to real dermatology work rather than reciting headings. They want to hear how it shapes your behaviour with patients, colleagues and in relation to safety.

 

Model answer

To me Good Medical Practice is the description of the doctor I'm trying to be every day, not something I think about only at appraisal. The current version is organised around four domains: knowledge, skills and development; patients, partnership and communication; colleagues, culture and safety; and trust and professionalism. I find it easiest to explain with what those look like in a normal dermatology week.

On knowledge and skills, it means knowing my limits. If I'm unsure about a dermoscopic pattern or whether a lesion needs a wider excision, I discuss it with a consultant rather than guess, and I keep my own skills current through audit, teaching and case review.

Partnership and communication is very visible in dermatology because so much of our treatment is shared decision making. A psoriasis patient choosing between phototherapy, methotrexate and a biologic needs honest information about benefits and risks to make a choice that suits their life. Consent for minor surgery is the same, especially talking about scarring on the face, which matters hugely to people.

Colleagues, culture and safety covers things like speaking up if I see unsafe practice, and treating colleagues with respect. The newer version is clearer about behaviours such as bullying and sexual harassment, and about doctors having a part to play in a fair, supportive culture, including for nurses and administrative staff who keep clinics running.

Trust and professionalism covers honesty, including the duty of candour if something goes wrong, and being careful about how I use social media, which is relevant in a specialty where patients often look for skin advice online. For me it all comes back to the patient being able to trust me.

 

Why this answer works

The answer names the four current domains accurately and then grounds each one in dermatology practice, which shows real understanding rather than memorisation. It also mentions the newer elements on culture and harassment, which demonstrates up-to-date knowledge.

 

Key points to include

• Name the four domains of the current Good Medical Practice
• Know your limits and seek senior advice
• Shared decision making and consent in dermatology
• Speaking up and a respectful team culture
• Honesty, duty of candour and professional behaviour online

 

Common mistakes to avoid

• Reciting headings without examples
• Quoting an outdated version of the guidance
• Forgetting the colleagues and culture domain
• Making it sound like a box-ticking exercise

 

NHS values and standards

Respect and dignity; Commitment to quality of care; Working together for patients; GMC Good Medical Practice

 

Further reading

• GMC Good Medical Practice (2024)
• GMC guidance on decision making and consent
• GMC and NMC joint guidance on the professional duty of candour
• GMC guidance on doctors' use of social media

 

 

Question 7: You are asked to see a 9-month-old on the children's ward with a 'rash'. On examination there are several bruises of different colours on the trunk and arms. What would you do?

Safeguarding question  ·  Safeguarding

 

What the interview panel is assessing

This tests whether you recognise that bruising in a non-mobile baby is a safeguarding red flag, that you avoid jumping to conclusions in either direction, and that you follow the local child protection process. The panel also wants to hear accurate dermatological knowledge, such as distinguishing bruising from congenital dermal melanocytosis, and thorough documentation.

 

Model answer

The first thing in my mind would be that bruising in a baby who isn't yet crawling or cruising is unusual, and national and local guidance is clear that it should prompt a safeguarding assessment unless there's a clear medical explanation. My job as the dermatologist is to describe accurately what I see, consider genuine skin or medical causes, and make sure the right people are involved, not to investigate on my own.

I'd examine the whole skin carefully with a parent and a nurse present, looking at the distribution, colour, pattern and whether there are marks in unusual places like the ears, neck, torso or genital area. I'd think about mimics. For example, congenital dermal melanocytosis, sometimes still called Mongolian blue spots, is common in babies with darker skin and can be mistaken for bruising, but it's usually present from birth, doesn't change colour over days and isn't tender. Other mimics include vasculitis, phytophotodermatitis and clotting disorders. I'd document everything with measurements, and request medical photography in line with the trust's policy.

In this case, bruises of different colours on the trunk and arms of a nine-month-old don't fit a skin condition, so I'd speak directly to the paediatric consultant responsible for the child straight away, and make sure the named or designated safeguarding lead is informed, following the trust's child protection procedure. The paediatric team would normally lead on the next steps, such as clotting screens, a skeletal survey and a referral to children's social care, but I'd make sure the referral actually happens rather than assume someone else has done it.

I'd be calm and honest with the parents. I'd explain that we need to look into how the marks happened, which is what we do for any baby with bruising, without accusing anyone. My notes would record exactly what I saw, what was said, using the parents' own words where relevant, and who I spoke to and when. Afterwards I'd talk it through with my consultant, because these cases can stay with you.

 

Why this answer works

The answer combines safeguarding knowledge with genuine dermatological expertise, which is exactly what the specialty adds. It recognises bruising in non-mobile infants as a red flag, considers mimics including dermal melanocytosis in darker skin, escalates promptly through the paediatric consultant and safeguarding lead, and covers documentation and honest, non-accusatory communication.

 

Key points to include

• Bruising in a non-mobile infant is a safeguarding red flag
• Careful full examination with a chaperone and accurate documentation
• Consider genuine mimics such as congenital dermal melanocytosis, vasculitis and clotting disorders
• Escalate immediately to the responsible paediatric consultant and safeguarding lead
• Follow the local child protection procedure and check the referral happens
• Calm, honest, non-accusatory communication with parents

 

Common mistakes to avoid

• Labelling it as a rash without considering safeguarding
• Accusing the parents or confronting them
• Assuming the paediatric team will handle it without checking
• Mistaking dermal melanocytosis for bruising, or the reverse, without careful assessment

 

NHS values and standards

Everyone counts; Compassion; Working together for patients; GMC guidance: Protecting children and young people

 

Further reading

• Working Together to Safeguard Children (England; equivalent guidance applies in Scotland, Wales and Northern Ireland)
• NICE guideline on child maltreatment: when to suspect
• GMC guidance: Protecting children and young people
• Children Act 1989 and 2004
• Local child protection and bruising in non-mobile infants policy

 

 

Question 8: Tell us about a time a test result or follow-up was missed, or nearly missed. What did you learn?

Patient Safety question  ·  Patient Safety

 

What the interview panel is assessing

The panel is assessing honesty, insight and how you respond to error. In dermatology, histology results from biopsies are a classic safety risk, so they want to hear what you did for the patient, how you were open, how the incident was reported and what changed afterwards.

 

Model answer

This happened during my first few months in dermatology. I took a punch biopsy from a scaly lesion on a man's lower leg in a general clinic. My working diagnosis was Bowen's disease, and I'd planned to review the result and write to him. A few weeks later, while preparing for a clinic, I realised I hadn't seen the result come through. When I checked the system, it had been reported ten days earlier as an invasive squamous cell carcinoma, and it was sitting in a results inbox that I hadn't been routinely checking.

I'll be honest, my stomach dropped. The first thing I did was tell my consultant, and we agreed to contact the patient that day. I phoned him, explained that the result had come back and showed a skin cancer that needed to be removed, and apologised that it had taken longer than it should for us to get in touch. He was understandably unhappy, but he appreciated being told directly. We booked him for excision within the cancer pathway and he was discussed at the skin MDT. Thankfully the delay didn't change his treatment, but it could have.

I completed an incident report the same day. Under PSIRF the department used it as a learning response rather than a blame exercise. It turned out the issue wasn't just me. Biopsies taken in general clinics weren't being tracked the same way as those from the skin cancer pathway, and responsibility depended on whoever had taken the sample.

What changed was that we set up a simple biopsy log with a named clinician, and the results inbox was reviewed by a nominated person each week as a backstop. Personally, I now never take a biopsy without writing in the notes how and when I'll check the result, and I keep my own list. It taught me that being open quickly is the right thing for the patient and makes things easier to fix.

 

Why this answer works

The answer is honest about a believable personal error and shows the right priorities: patient first, senior involvement, open disclosure and an apology in line with the duty of candour. It uses PSIRF correctly and shows both system learning and a lasting change in personal practice.

 

Key points to include

• A real, specific example where you took responsibility
• Patient safety first: prompt contact and treatment
• Openness, apology and the duty of candour
• Incident reporting and system learning under PSIRF
• A concrete change in your own practice and the department's

 

Common mistakes to avoid

• Choosing an example that is not really a mistake
• Blaming the system or colleagues entirely
• Not mentioning telling the patient
• No clear learning or change afterwards

 

NHS values and standards

Commitment to quality of care; Respect and dignity; GMC Good Medical Practice: colleagues, culture and safety; Professional duty of candour

 

Further reading

• GMC and NMC joint guidance on the professional duty of candour
• NHS England Patient Safety Incident Response Framework (PSIRF)
• GMC Good Medical Practice
• Local policy on test result management and acknowledgement

 

 

Unlock 32 more NHS interview questions

You have read the free questions. The full bank adds 32 premium questions for this role, each with a model answer, what the panel is assessing, key points and common mistakes.

One-off payment of £2.99 for 12 months' access. No subscription. Use the Unlock button at the top of this page.